Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing ...

Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Hello, and welcome to Inseego Corp’s First Quarter 2025 Financial Results Conference Call. Please note that today’s event is being recorded. All ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...